Interestingly, the prognostic value of MGL-binding to tumor cells is predominantly evident in stage III colon cancer patients and not in stage II patients, i.e. when tumor cells are no longer confined to the intestine but have spread into the local lymph-nodes. Here, CLEC10A is linked to colonic neoplasm.